Global Nuclear Medicine/Radiopharmaceuticals Market Survey Report 2018 | China Isotope & Radiation, Dongcheng, Jaco, Ciaeriar

Qyresearchreports include new market research report “Global Nuclear Medicine/Radiopharmaceuticals Market Research Report 2018” to its huge collection of research reports.

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imagedfor example, positronemitting radiopharmaceuticals.

Click to get Sample PDF: https://www.qyresearchreports.com/sample/sample.php?rep_id=1831571&type=S

Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.

In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.

The major manufacturers covered in this report
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic
Therapeutic
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Oncology
Thyroid
Cardiology

The study objectives of this report are:

To analyze and study the global Nuclear Medicine/Radiopharmaceuticals sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Nuclear Medicine/Radiopharmaceuticals manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

Read Comprehensive Overview of Report @ https://www.qyresearchreports.com/report/global-nuclear-medicineradiopharmaceuticals-market-research-report-2018.htm

Key Stakeholders
Nuclear Medicine/Radiopharmaceuticals Manufacturers
Nuclear Medicine/Radiopharmaceuticals Distributors/Traders/Wholesalers
Nuclear Medicine/Radiopharmaceuticals Subcomponent Manufacturers
Industry Association
Downstream Vendors

QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

1820 Avenue
M Suite #1047
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Web: http://www.qyresearchreports.com
Email: sales@qyresearchreports.com

This release was published on openPR.